PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -87.5% | 200 | -75.0% | 0.00% | – |
| Q4 2020 | $8,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | +33.3% | 800 | +33.3% | 0.00% | – |
| Q2 2020 | $6,000 | -82.4% | 600 | -89.0% | 0.00% | -100.0% |
| Q1 2020 | $34,000 | +209.1% | 5,450 | +109.6% | 0.00% | +100.0% |
| Q4 2019 | $11,000 | +10.0% | 2,600 | +13.0% | 0.00% | 0.0% |
| Q3 2019 | $10,000 | -94.5% | 2,300 | -80.7% | 0.00% | -94.1% |
| Q2 2019 | $183,000 | -9.0% | 11,900 | -14.3% | 0.02% | -19.0% |
| Q1 2019 | $201,000 | +27.2% | 13,880 | -36.0% | 0.02% | +50.0% |
| Q4 2018 | $158,000 | -86.4% | 21,677 | -63.4% | 0.01% | -82.5% |
| Q3 2018 | $1,158,000 | -6.7% | 59,151 | -4.2% | 0.08% | -19.2% |
| Q2 2018 | $1,241,000 | +54.4% | 61,747 | +25.4% | 0.10% | +43.5% |
| Q1 2018 | $804,000 | -70.2% | 49,237 | -56.1% | 0.07% | -37.8% |
| Q4 2017 | $2,700,000 | +26.3% | 112,040 | -16.2% | 0.11% | +38.8% |
| Q3 2017 | $2,138,000 | -62.1% | 133,676 | -59.1% | 0.08% | -61.5% |
| Q2 2017 | $5,641,000 | +486.4% | 326,473 | +277.4% | 0.21% | +407.3% |
| Q1 2017 | $962,000 | -29.6% | 86,506 | -11.0% | 0.04% | -16.3% |
| Q4 2016 | $1,367,000 | +45.6% | 97,146 | -16.6% | 0.05% | +14.0% |
| Q3 2016 | $939,000 | +153.8% | 116,534 | +155.2% | 0.04% | +126.3% |
| Q2 2016 | $370,000 | -65.4% | 45,666 | -48.7% | 0.02% | -72.9% |
| Q1 2016 | $1,068,000 | +1.1% | 88,993 | -16.1% | 0.07% | +20.7% |
| Q4 2015 | $1,056,000 | – | 106,081 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |